Global Collaborators 'cunning plan' for affordable, accessib

The consortium’s strategy is to create an AI-driven Structure-enabled Antiviral Platform (ASAP), using cutting-edge technology such as advanced structural biology, fragment screening, AI and machine learning, as well as computational chemistry on Folding@home, the world’s largest distributed computing platform to build a robust and open access antiviral discovery pipeline. Click to read more...

Related Keywords

New York , United States , Japan , United Kingdom , Israel , Tel Aviv , Brazil , Geneva , Genè , Switzerland , Japanese , Tamas Szommer , Daren Fearon , Alpha Lee , Brian Marsden , Oleg Fedorov , Eleanor Williams , Centre For Medicines Discovery , Stanford University School Of Medicine United States , Research Informatics , University Of Oxford , National Institute Of Allergy , Weizmann Institute Of Science Israel , Antiviral Program For Pandemics , Memorial Sloan Kettering Cancer Centre United States , Structural Genomic Consortium , Wellcome Trust , Team Leader , Fred Hutchinson Cancer Center United States , Structure Enabled Antiviral Platform , Palo Alto , Antiviral Drug Discovery , Pandemic Concern , National Institute , Infectious Diseases , Antiviral Program , Chief Scientific Officer , Medicines Discovery , Senior Beamline Scientist , Diamond Light Source , Professor Brian Marsden , Consistentx Ray , Diamond Synchrotron , Memorial Sloan Kettering Cancer Centre , Weizmann Institute , Mount Sinai , Stanford University School , Fred Hutchinson Cancer Center , Neglected Diseases , Yasap , Discovery , Drug , Crystallisation , Work , Moonshot , Science , Targets , Fragment , Protein ,